If government strategy isn’t coherent, it’s a complete waste of money
More must be done to equip biotech in Quebec, especially in supporting the growth of small players, so they don’t have to accept a foreign takeover for lack of capital access.
When it comes to science and technology, government involvement is key.
Let’s take the pharmaceutical industry as an example. From 1969 to 1987, the mandatory licensing regime offered little patent protection, driving up the production of generics in Ontario. Ontario was pleased with this policy ...
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
